Top Markets
Coin of the day
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Rank in Stocks #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Share Price
$0.05207079
Last synced: 2023-11-15
Market Cap
$3.38M
Change (1 day)
0.13%
Change (1 year)
0.00%
Country
AU
Trade Kazia Therapeutics Limited (KZA)

Category

Stock split history for Kazia Therapeutics Limited (KZA)
Kazia Therapeutics Limited stock (symbol: KZA) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 16, 2026.
One KZA share bought prior to Aug 16, 2026 would equal to 0 KZA shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE